Femasys Inc. (FEMY)
NASDAQ: FEMY · IEX Real-Time Price · USD
1.180
0.00 (0.00%)
At close: May 31, 2024, 4:00 PM
1.210
+0.030 (2.54%)
After-hours: May 31, 2024, 7:17 PM EDT
Femasys Market Cap
Femasys has a market cap or net worth of $26.22 million as of May 31, 2024. Its market cap has increased by 164.85% in one year.
Market Cap
26.22M
Enterprise Value
15.25M
1-Year Change
164.85%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on June 18, 2021, Femasys's market cap has decreased from $152.90M to $26.22M, a decrease of -82.85%. That is a compound annual growth rate of -44.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 26.20M | - |
May 30, 2024 | 26.20M | 0.77% |
May 29, 2024 | 26.00M | -3.35% |
May 28, 2024 | 26.90M | -5.28% |
May 24, 2024 | 28.40M | 2.90% |
May 23, 2024 | 27.60M | -4.50% |
May 22, 2024 | 28.90M | 1.76% |
May 21, 2024 | 28.40M | 1.43% |
May 20, 2024 | 28.00M | -0.71% |
May 17, 2024 | 28.20M | -1.74% |
May 16, 2024 | 28.70M | -3.04% |
May 15, 2024 | 29.60M | -3.58% |
May 14, 2024 | 30.70M | 8.87% |
May 13, 2024 | 28.20M | 4.83% |
May 10, 2024 | 26.90M | -4.61% |
May 9, 2024 | 28.20M | -8.14% |
May 8, 2024 | 30.70M | -2.23% |
May 7, 2024 | 31.40M | 5.37% |
May 6, 2024 | 29.80M | 4.56% |
May 3, 2024 | 28.50M | 4.40% |
May 2, 2024 | 27.30M | -4.88% |
May 1, 2024 | 28.70M | 2.14% |
Apr 30, 2024 | 28.10M | -3.77% |
Apr 29, 2024 | 29.20M | 3.91% |
Apr 26, 2024 | 28.10M | -4.42% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
RenovoRx | 27.78M |
Viracta Therapeutics | 27.49M |
Oncternal Therapeutics | 27.26M |
Singular Genomics Systems | 27.02M |
Accelerate Diagnostics | 26.24M |
Unity Biotechnology | 26.02M |
Aprea Therapeutics | 25.90M |
Aptorum Group | 25.80M |